Luis Paz‐Ares

2 ta ish

Centro de Investigación Biomédica en Red de Cáncer

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

   Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.170111

2. Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer

   Matthew D. Hellmann, Luis Paz‐Ares, Reyes Bernabe Caro +23

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.826278